title: Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.
abstract: Apolipoprotein AIV (apo AIV) and cholecystokinin (CCK) are satiation factors secreted by the small intestine in response to lipid meals. Apo AIV and CCK-8 has an additive effect to suppress food intake relative to apo AIV or CCK-8 alone. In this study, we determined whether CCK-8 (1, 3, or 5 μg/kg ip) reduces food intake in fasted apo AIV knockout (KO) mice as effectively as in fasted wild-type (WT) mice. Food intake was monitored by the DietMax food system. Apo AIV KO mice had significantly reduced 30-min food intake following all doses of CCK-8, whereas WT mice had reduced food intake only at doses of 3 μg/kg and above. Post hoc analysis revealed that the reduction of 10-min and 30-min food intake elicited by each dose of CCK-8 was significantly larger in the apo AIV KO mice than in the WT mice. Peripheral CCK 1 receptor (CCK1R) gene expression (mRNA) in the duodenum and gallbladder of the fasted apo AIV KO mice was comparable to that in WT mice. In contrast, CCK1R mRNA in nodose ganglia of the apo AIV KO mice was upregulated relative to WT animals. Similarly, upregulated CCK1R gene expression was found in the brain stem of apo AIV KO mice by in situ hybridization. Although it is possible that the increased satiating potency of CCK in apo AIV KO mice is mediated by upregulation of CCK 1R in the nodose ganglia and nucleus tractus solitarius, additional experiments are required to confirm such a mechanism.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Cincinnati, OH 45237, USA.
authors.forename: Go
authors.initials: G
authors.lastname: Yoshimichi
authors.forename: Chunmin C
authors.initials: CC
authors.lastname: Lo
authors.forename: Kellie L K
authors.initials: KL
authors.lastname: Tamashiro
authors.forename: Liyun
authors.initials: L
authors.lastname: Ma
authors.forename: Dana M
authors.initials: DM
authors.lastname: Lee
authors.forename: Denovan P
authors.initials: DP
authors.lastname: Begg
authors.forename: Min
authors.initials: M
authors.lastname: Liu
authors.forename: Randall R
authors.initials: RR
authors.lastname: Sakai
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Woods
authors.forename: Hironobu
authors.initials: H
authors.lastname: Yoshimatsu
authors.forename: Patrick
authors.initials: P
authors.lastname: Tso
mesh_terms: D000818:Animals; D001054:Apolipoproteins A / Q000235:genetics / Q000378:metabolism*; D002766:Cholecystokinin / Q000494:pharmacology*; D004386:Duodenum / Q000378:metabolism; D004435:Eating / Q000187:drug effects* / Q000235:genetics; D005247:Feeding Behavior / Q000187:drug effects* / Q000502:physiology; D005704:Gallbladder / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009620:Nodose Ganglion / Q000378:metabolism; D011949:Receptors, Cholecystokinin / Q000235:genetics / Q000378:metabolism; D012527:Satiation / Q000187:drug effects* / Q000502:physiology
chemical_list: D001054:Apolipoproteins A; D011949:Receptors, Cholecystokinin; C022205:apolipoprotein A-IV; D002766:Cholecystokinin